On July 17, Ascentage Pharma fell 8.49% in regular trading, trading at HK$35.98/share, with turnover of HK$117 million.
Within the Biotechnology sector where Ascentage Pharma belongs, the overall sector decline is significant. Among individual stocks, AKESO down 12.28%, 3SBIO down 9.88%, SKB BIO down 5.84%, INNOVENT BIO down 5.47%, BEIGENE down 2.15%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)